Alpha Financial Partners, LLC Merck & Co., Inc. Transaction History

Alpha Financial Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $23,150 - $24,863	-187 Reduced 8.58%	1,993 $247 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $40,879 - $47,633	-361 Reduced 14.21%	2,180 $288 Million
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $44,680 - $48,622	-446 Reduced 14.93%	2,541 $277 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $3,706 - $4,115	-36 Reduced 1.19%	2,987 $308 Million
Q2 2023 Jul 27, 2023	BUY	$108.61 - $118.38 $48,548 - $52,915	447 Added 17.35%	3,023 $349 Million
Q1 2023 May 10, 2023	BUY	$102.94 - $114.86 $50,440 - $56,281	490 Added 23.49%	2,576 $274 Million
Q4 2022 Feb 16, 2023	BUY	$87.44 - $112.11 $182,399 - $233,861	2,086 New	2,086 $231 Million

3,802

1.92B

13.4M

10.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Alpha Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Financial Partners, LLC with notifications on news.